Meng H Tan1, Steven J Bernstein2, Stephen Gendler3, David Hanauer4, William H Herman5. 1. Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: mengt@med.umich.edu. 2. Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA; Center for Clinical Management Research, VA Ann Arbor Healthcare System, USA. 3. Medical School Information Services, University of Michigan, Ann Arbor, MI, USA. 4. Division of General Pediatrics, Department of Pediatrics and Communicable Disease, University of Michigan, Ann Arbor, MI, USA. 5. Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND AND AIM: A major challenge in conducting clinical trials/studies is the timely recruitment of eligible subjects. Our aim is to develop a Diabetes Research Registry (DRR) to facilitate recruitment by matching potential subjects interested in research with approved clinical studies using study entry criteria abstracted from their electronic health records (EHR). METHOD: A committee with expertise in diabetes, quality improvement, information technology, and informatics designed and developed the DRR. Using a hybrid approach, we identified and consented patients interested in research, abstracted their EHRs to assess common eligibility criteria, and contacted them about their interest in participating in specific studies. Investigators submit their requests with study entry criteria to the DRR which then provides a list of potential subjects who may be directly contacted for their study. The DRR meets all local, regional and federal regulatory requirements. RESULTS: After 5 years, the DRR has over 5000 registrants. About 30% have type 1 diabetes and 70% have type 2 diabetes. There are almost equal proportions of men and women. During this period, 31 unique clinical studies from 19 unique investigators requested lists of potential subjects for their studies. Eleven grant applications from 10 unique investigators used aggregated counts of potentially eligible subjects in their applications. CONCLUSION: The DRR matches potential subjects interested in research with approved clinical studies using study entry criteria abstracted from their EHR. By providing large lists of potentially eligible study subjects quickly, the DRR facilitated recruitment in 31 clinical studies.
BACKGROUND AND AIM: A major challenge in conducting clinical trials/studies is the timely recruitment of eligible subjects. Our aim is to develop a Diabetes Research Registry (DRR) to facilitate recruitment by matching potential subjects interested in research with approved clinical studies using study entry criteria abstracted from their electronic health records (EHR). METHOD: A committee with expertise in diabetes, quality improvement, information technology, and informatics designed and developed the DRR. Using a hybrid approach, we identified and consented patients interested in research, abstracted their EHRs to assess common eligibility criteria, and contacted them about their interest in participating in specific studies. Investigators submit their requests with study entry criteria to the DRR which then provides a list of potential subjects who may be directly contacted for their study. The DRR meets all local, regional and federal regulatory requirements. RESULTS: After 5 years, the DRR has over 5000 registrants. About 30% have type 1 diabetes and 70% have type 2 diabetes. There are almost equal proportions of men and women. During this period, 31 unique clinical studies from 19 unique investigators requested lists of potential subjects for their studies. Eleven grant applications from 10 unique investigators used aggregated counts of potentially eligible subjects in their applications. CONCLUSION: The DRR matches potential subjects interested in research with approved clinical studies using study entry criteria abstracted from their EHR. By providing large lists of potentially eligible study subjects quickly, the DRR facilitated recruitment in 31 clinical studies.
Authors: Sabrina Bernardez-Pereira; Renato D Lopes; Maria Julia Machline Carrion; Eliana Vieira Santucci; Rafael Marques Soares; Matheus de Oliveira Abreu; Ligia Nasi Laranjeira; Dimas T Ikeoka; Ana Denise Zazula; Frederico Rafael Moreira; Alexandre Biasi Cavalcanti; Evandro Tinoco Mesquita; Eric D Peterson; Robert M Califf; Otavio Berwanger Journal: Am Heart J Date: 2014-05-02 Impact factor: 4.749
Authors: Alison M McDonald; Rosemary C Knight; Marion K Campbell; Vikki A Entwistle; Adrian M Grant; Jonathan A Cook; Diana R Elbourne; David Francis; Jo Garcia; Ian Roberts; Claire Snowdon Journal: Trials Date: 2006-04-07 Impact factor: 2.279
Authors: Minal R Patel; Michele Heisler; John D Piette; Kenneth Resnicow; Peter X K Song; Hae Mi Choe; Xu Shi; Julie Tobi; Alyssa Smith Journal: Contemp Clin Trials Date: 2020-01-07 Impact factor: 2.226
Authors: Jennifer Elston Lafata; Deirdre A Shires; Yongyun Shin; Susan Flocke; Kenneth Resnicow; Morgan Johnson; Ellen Nixon; Xinxin Sun; Sarah Hawley Journal: Med Decis Making Date: 2022-06-28 Impact factor: 2.749
Authors: Catherine M Hammack-Aviran; Kathleen M Brelsford; Kevin C McKenna; Ross D Graham; Zachary M Lampron; Laura M Beskow Journal: AJOB Empir Bioeth Date: 2020-04-27
Authors: Jihad S Obeid; Laura M Beskow; Marie Rape; Ramkiran Gouripeddi; R Anthony Black; James J Cimino; Peter J Embi; Chunhua Weng; Rebecca Marnocha; John B Buse Journal: J Clin Transl Sci Date: 2017-08
Authors: Minal R Patel; Guanghao Zhang; Cindy Leung; Peter X K Song; Michele Heisler; Hae Mi Choe; Roshanak Mehdipanah; Xu Shi; Kenneth Resnicow; Geila Rajaee; John D Piette Journal: Prim Care Diabetes Date: 2021-10-29 Impact factor: 2.459
Authors: Gia J Oh; Anne Waldo; Francisco Paez-Cruz; Patrick E Gipson; Anne Pesenson; David T Selewski; Elaine S Kamil; Susan F Massengill; Richard A Lafayette; Meg Modes; Sharon G Adler; Hailey Desmond; Richard Eikstadt; Samara Attalla; Zubin J Modi; Jonathan P Troost; Debbie S Gipson Journal: Kidney Int Rep Date: 2019-09-09